Actively Recruiting

Age: 19Years +
All Genders
NCT07452432

Korean Prospective Upper Tract Urothelial Carcinoma Cohort

Led by Samsung Medical Center · Updated on 2026-03-05

300

Participants Needed

1

Research Sites

230 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a single-center, prospective, non-interventional observational cohort study designed to establish a structured recurrence monitoring platform in Korean patients with high-grade non-metastatic upper tract urothelial carcinoma (UTUC). Eligible adult patients scheduled to receive neoadjuvant chemotherapy followed by radical nephroureterectomy will undergo circulating tumor DNA (ctDNA) sampling prior to chemotherapy initiation and once between 1-6 months after surgery. Clinical, imaging, pathological, and longitudinal follow-up data will be prospectively collected to enable long-term monitoring of recurrence and survival outcomes. The primary objective is to establish a prospective cohort integrating clinical and molecular data to support future translational research and recurrence prediction modeling in UTUC.

CONDITIONS

Official Title

Korean Prospective Upper Tract Urothelial Carcinoma Cohort

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 19 years or older
  • Histologically confirmed high-grade upper tract urothelial carcinoma (renal pelvis and/or ureter)
  • Clinical stage cT2-T4, cN0-1, M0 disease
  • Planned neoadjuvant chemotherapy followed by radical nephroureterectomy
  • ECOG performance status of 0 or 1
  • Adequate blood, liver, and kidney function
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Evidence of distant metastasis (M1)
  • Contraindication to cisplatin-based chemotherapy
  • Uncontrolled infection or severe comorbid medical condition
  • Pregnancy or breastfeeding
  • Any condition that makes participation inappropriate as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Samsung Medical Center

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

J

Jiwoong Yu, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here